We are live on ! Find out more
APLT

Applied Therapeutics
APLT

Delisted

APLT was delisted on the 2nd of February, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of APLT yet.

APLT Hedge Fund Activity: Q1 2026 in Review

0 of the 8,145 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q1 2026, worth a combined $0 — down 100% from $5.93M a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of APLT and 0 opened new positions — a net loss of 51 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $2.17M sold.

  • 0 institutional investors held Applied Therapeutics (APLT) as of Q1 2026, down from 52 in Q4 2025.
  • Funds reported $0 of Applied Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Applied Therapeutics positions in Q1 2026 and 51 closed out, a net change of -51 holders.
  • The largest Applied Therapeutics seller in Q1 2026 was T. Rowe Price Investment Management, an estimated $2.17M sold.

Based on aggregated 13F filings for Q1 2026.